Proceedings of the National Academy of Sciences,
Journal Year:
2023,
Volume and Issue:
120(3)
Published: Jan. 10, 2023
The
lack
of
techniques
for
noninvasive
imaging
inflammation
has
challenged
precision
medicine
management
acute
respiratory
distress
syndrome
(ARDS).
Here,
we
determined
the
potential
positron
emission
tomography
(PET)
chemokine-like
receptor-1
(CMKLR1)
to
monitor
lung
in
a
murine
model
lipopolysaccharide-induced
injury.
Lung
uptake
CMKLR1-targeting
radiotracer,
[
64
Cu]NODAGA-CG34,
was
significantly
increased
injury,
correlated
with
expression
multiple
inflammatory
markers,
and
reduced
by
dexamethasone
treatment.
Monocyte-derived
macrophages,
followed
interstitial
macrophages
monocytes
were
major
CMKLR1-expressing
leukocytes
contributing
tracer
throughout
first
week
clinical
relevance
CMKLR1
as
biomarker
ARDS
confirmed
using
single-nuclei
RNA-sequencing
datasets
which
showed
significant
increases
among
transcriptionally
distinct
subsets
COVID-19
patients
vs.
controls.
CMKLR1-targeted
PET
is
promising
strategy
dynamics
response
anti-inflammatory
treatment
ARDS.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Jan. 9, 2023
Abstract
The
ribosome
is
a
multi-unit
complex
that
translates
mRNA
into
protein.
Ribosome
biogenesis
the
process
generates
ribosomes
and
plays
an
essential
role
in
cell
proliferation,
differentiation,
apoptosis,
development,
transformation.
mTORC1,
Myc,
noncoding
RNA
signaling
pathways
are
primary
mediators
work
jointly
with
polymerases
proteins
to
control
protein
synthesis.
Activation
of
mTORC1
required
for
normal
fetal
growth
development
tissue
regeneration
after
birth.
Myc
implicated
cancer
by
enhancing
Pol
II
activity,
leading
uncontrolled
growth.
deregulation
RNAs
such
as
microRNAs,
long
RNAs,
circular
involved
developing
blood,
neurodegenerative
diseases,
atherosclerosis.
We
review
similarities
differences
between
eukaryotic
bacterial
molecular
mechanism
ribosome-targeting
antibiotics
resistance.
also
most
recent
findings
dysfunction
COVID-19
other
conditions
discuss
consequences
frameshifting,
ribosome-stalling,
ribosome-collision.
summarize
various
diseases.
Furthermore,
we
current
clinical
trials,
prospective
vaccines
COVID-19,
therapies
targeting
cancer,
cardiovascular
disease,
aging,
disease.
Cell Death and Disease,
Journal Year:
2022,
Volume and Issue:
13(6)
Published: June 6, 2022
Abstract
Compelling
evidences
have
revealed
the
emerging
role
of
ferroptosis
in
pathophysiological
process
acute
lung
injury
(ALI),
but
its
modulation
is
not
clear.
Here,
we
identified
that
STAT6
acted
as
a
critical
regulator
epithelium
during
ALI.
Firstly,
expression
and
activity
were
increased
ALI
mice
models
caused
by
crystalline
silica
(CS),
LPS
X-ray
exposure.
Followed
confirming
contribution
above
with
ferrostatin-1
deferoxamine
intervention,
bioinformatic
analyses
was
negatively
correlated
ferroptosis.
Consistently,
epithelium-specific
depletion
or
knockdown
cultured
epithelial
cells
exacerbated
While
overexpression
attenuated
Mechanistically,
SLC7A11
typical
ferroptosis-related
gene
regulated
P53.
CREB-binding
protein
(CBP)
acetyltransferase
P53
acetylation,
showing
valuable
regulation
on
targets’
transcription.
Herein,
found
regulates
through
competitively
binding
CBP,
which
inhibits
acetylation
transcriptionally
restores
expression.
Finally,
pulmonary-specific
decreased
CS
induced
injury.
Our
findings
pivotal
ferroptosis,
may
be
potential
therapeutic
target
for
treatment
Acute
lung
injury
(ALI)
has
received
considerable
attention
in
the
field
of
intensive
care
as
it
is
associated
with
a
high
mortality
rate.
Obacunone
(OB),
widely
found
citrus
fruits,
natural
bioactive
compound
anti-inflammatory
and
antioxidant
activities.
However,
not
clear
whether
OB
protects
against
lipopolysaccharide
(LPS)-induced
ALI.
Therefore,
this
study,
we
aimed
to
evaluate
protective
effects
potential
mechanisms
LPS-induced
ALI
BEAS-2B
cell
injury.We
established
model
mouse
by
treating
LPS.
Samples
vitro
were
subjected
death,
Cell
Counting
Kit-8,
lactate
dehydrogenase
(LDH)
release
assays.
The
total
number
cells
neutrophils,
protein
content,
levels
IL-6,
TNF-α,
IL-1β
determined
bronchoalveolar
lavage
fluid
(BALF).
Glutathione,
reactive
oxygen
species,
malondialdehyde
tissue.
Additionally,
immunohistochemical
analysis,
immunofluorescence,
western
blot,
quantitative
real-time
PCR,
enzyme-linked
immunosorbent
assay
conducted
examine
OB.
Furthermore,
mice
treated
an
Nrf2
inhibitor
(ML385)
verify
its
role
ferroptosis.
Data
analyzed
using
one-way
analysis
variance
or
paired
t-tests.Compared
LPS
group,
effectively
alleviated
decreasing
wet/dry
weight
ratio,
species
production,
superoxide
dismutase
glutathione
consumption
vivo.
In
addition,
significantly
histopathological
injury,
reduced
inflammatory
cytokine
secretion
Fe2+
4-HNE
levels,
upregulated
GPX4,
SLC7A11,
expression.
Mechanistically,
activated
inhibiting
ubiquitinated
proteasome
degradation.
ML385
reversed
ALI.Overall,
alleviates
ALI,
making
novel
agent
American Journal of Respiratory and Critical Care Medicine,
Journal Year:
2024,
Volume and Issue:
210(2), P. 155 - 166
Published: April 30, 2024
Critical
care
uses
syndromic
definitions
to
describe
patient
groups
for
clinical
practice
and
research.
There
is
growing
recognition
that
a
"precision
medicine"
approach
required
integrated
biologic
physiologic
data
identify
reproducible
subpopulations
may
respond
differently
treatment.
This
article
reviews
the
current
state
of
field
considers
how
successfully
transition
precision
medicine
approach.
To
impact
care,
identification
must
do
more
than
differentiate
prognosis.
It
response
treatment,
ideally
by
defining
subgroups
with
distinct
functional
or
pathobiological
mechanisms
(endotypes).
are
now
multiple
examples
sepsis,
acute
respiratory
distress
syndrome,
kidney
brain
injury
described
using
clinical,
physiological,
and/or
biological
data.
Many
these
have
demonstrated
potential
define
differential
treatment
response,
largely
in
retrospective
studies,
same
treatment-responsive
cross
syndromes
(treatable
traits).
bring
about
change
practice,
be
evaluated
prospective
studies
requiring
novel
adaptive
trial
designs.
Several
such
underway,
but
there
challenges
tackled.
Such
readily
identifiable
applicable
all
critically
ill
populations
around
world.
Subdividing
into
will
require
large
numbers.
Global
collaboration
investigators,
clinicians,
industry,
patients
over
many
years
therefore
ultimately
realize
advances
seen
other
medical
fields.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
172, P. 116233 - 116233
Published: Feb. 2, 2024
Acute
lung
injury
(ALI)
is
characterized
by
pulmonary
diffusion
abnormalities
that
may
progress
to
multiple-organ
failure
in
severe
cases.
There
are
limited
effective
treatments
for
ALI,
which
makes
the
search
new
therapeutic
avenues
critically
important.
Macrophages
play
a
pivotal
role
pathogenesis
of
ALI.
The
degree
macrophage
polarization
closely
related
severity
and
prognosis
S100A9
promotes
M1
macrophages.
present
study
assessed
effects
S100A9-gene
deficiency
on
acute
injury.
Our
cohort
showed
plasma
S100A8/A9
levels
had
significant
diagnostic
value
pediatric
pneumonia
primarily
correlated
with
monocyte-macrophages
neutrophils.
We
established
lipopolysaccharide
(LPS)-induced
mouse
model
demonstrated
knockout
gene
mitigated
inflammation
suppressing
secretion
pro-inflammatory
cytokines,
reducing
number
inflammatory
cells
bronchoalveolar
lavage
fluid,
inhibiting
cell
apoptosis,
ameliorated
mice.
vitro
vivo
mechanistic
studies
inhibited
reduced
chemotactic
factors
cytokines
TLR4/MyD88/NF-κB
signaling
pathway
reversing
expression
NLRP3
pyroptosis
pathway,
death.
In
conclusion,
alleviated
LPS-induced
via
TLR4/MyD88/NFκB
suggests
potential
strategy
treatment
Intensive Care Medicine Experimental,
Journal Year:
2022,
Volume and Issue:
10(1)
Published: March 11, 2022
Abstract
The
pathophysiology
of
acute
respiratory
distress
syndrome
(ARDS)
includes
the
accumulation
protein-rich
pulmonary
edema
in
air
spaces
and
interstitial
areas
lung,
variable
degrees
epithelial
injury,
endothelial
barrier
disruption,
transmigration
leukocytes,
alongside
impaired
fluid
ion
clearance.
These
pathophysiological
features
are
different
between
patients
contributing
to
substantial
biological
heterogeneity.
In
this
context,
it
is
perhaps
unsurprising
that
a
wide
range
pharmacological
interventions
targeting
these
processes
have
failed
improve
patient
outcomes.
manuscript,
our
goal
provide
narrative
summary
potential
methods
capture
underlying
heterogeneity
ARDS
discuss
how
information
could
inform
future
redefinitions.
We
what
tests
available
identify
with
any
following
predominant
patterns:
(1)
and/or
(2)
protein
rich
(3)
systemic
or
within
lung
inflammatory
responses.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: March 9, 2023
Acute
lung
injury
(ALI)
is
a
life-threatening
disease
with
high
incidence
and
mortality
rates.
Urolithin
A
(UA)
pomegranate
intestinal
flora
metabolite
anti-inflammatory,
antioxidant,
anti-aging
properties.
Ferroptosis
critical
factor
in
lipopolysaccharide
(LPS)-induced
acute
(ALI).
However,
the
link
between
UA
ferroptosis
unknown.
The
purpose
of
this
research
was
to
look
into
role
regulating
LPS-induced
ALI.
current
study
used
LPS
injure
two
models,
one
BEAS-2B
cell
model
ALI
mouse
model.
effectively
alleviated
compared
group
by
lowering
vivo
wet/dry
weight
ratio,
reactive
oxygen
species,
malondialdehyde
production,
as
well
superoxide
dismutase,
catalase,
glutathione
depletion.
Furthermore,
increasing
GPX4
SLC7A11
expression
decreasing
Fe2+
levels,
histopathological
damage,
inflammatory
cytokine
secretion,
levels
can
be
significantly
reduced.
Keap1-Nrf2/HO-1
pathway
upregulated
UA,
which
inhibited
ferroptosis.
ML385
UA's
protective
effect
against
These
findings
suggested
that
could
novel
potential
therapeutic
target
for
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Nov. 14, 2023
Acute
respiratory
distress
syndrome
(ARDS)
is
an
acute
diffuse
inflammatory
lung
injury
characterized
by
the
damage
of
alveolar
epithelial
cells
and
pulmonary
capillary
endothelial
cells.
It
mainly
manifested
non-cardiogenic
edema,
resulting
from
intrapulmonary
extrapulmonary
risk
factors.
ARDS
often
accompanied
immune
system
disturbance,
both
locally
in
lungs
systemically.
As
a
common
heterogeneous
disease
critical
care
medicine,
researchers
are
faced
with
failure
clinical
trials.
Latent
class
analysis
had
been
used
to
compensate
for
poor
outcomes
found
that
targeted
treatment
after
subgrouping
contribute
therapy.
The
subphenotype
caused
sepsis
has
garnered
attention
due
its
refractory
nature
detrimental
consequences.
Sepsis
stands
as
most
predominant
cause
ARDS,
accounting
approximately
32%
cases.
Studies
indicate
sepsis-induced
tends
be
more
severe
than
other
factors,
leading
poorer
prognosis
higher
mortality
rate.
This
comprehensive
review
delves
into
immunological
mechanisms
sepsis-ARDS,
heterogeneity
existing
research
on
treatments,
aiming
providing
mechanism
understanding
exploring
ideas
accurate
or
sepsis-ARDS.